Flexion Therapeutics, Inc. News
5 Top Stock Gainers for Monday: Aspen, SoFi, Flexion Therapeutics
Aspen Technology, Sofi Technologies, Flexion Therapeutics, Adamas Pharmaceuticals and Ocular Therapeutix are five top stock gainers for Monday.
Premarket Movers Monday - Southwest Airlines, Alibaba, Robinhood
Stocks moving in premarket trading Monday include Southwest Airlines, Occidental Petroleum, Alibaba and Robinhood.
Flexion Surges on FDA Label-Update Approval, Analyst Price-Target Lift
Shares gain after FDA approves expanded label description for Zilretta osteoarthritis knee pain treatment; Raymond James lifts price target.
Flexion Could Draw Increased Takeover Interest After Drug Approval
The Burlington, Mass.-based pharmaceutical firm on Oct. 6 secured approval from the Food and Drug Administration for its osteoarthritis knee pain treatment Zilretta, a non-opioid medicine.
Flexion Secures FDA Nod for Osteoarthritis Knee Pain Treatment
The Burlington, Mass.-based firm received FDA approval for Zilretta, a non-opioid medicine utilizing Flexion's microsphere technology.
Biotech Movers: Akebia Soars on Expanded Partnership With Otsuka
Akebia after the market close on Tuesday announced an expanded partnership with Japan's Otsuka Pharmaceuticals to develop and market its anemia pill Vadadustat in Europe, China and other territories.
Stocks Fall as House Leaders Delay Health Care Vote
Stocks fall on Thursday afternoon after House leaders delay a highly anticipated vote on the Republicans' repeal-and-replace health care bill.
Sanofi Said to Be Near $1 Billion Deal for Flexion
Flexion is an arthritis-focused biotech company.
Pfizer Stock Active As Soft Covid Vaccine Sales Outlook Mars Q4 Earnings Beat
"As we turn to 2023, we expect to once again set records, with potentially the largest number of new product and indication launches that we’ve ever had in such a short period of time," said CEO Albert Bourla.
UPS Earnings Top Street Forecasts On Margin Focus, Revenues Miss; New $5 Billion Share Buyback Unveiled
UPS topped Street forecasts for its fourth quarter earnings, but a slump in international deliveries kept revenue gain in check.
General Motors Stock Surges As Earnings Blast Street Forecasts; Sees Robust 2023 Profits
GM blasted Street profit forecasts with adjusted earnings of $2.12 per share on revenues of $43.1 billion.
Exxon Mobil Posts Record $56 Billion 2022 Profit, Beats Q4 Forecasts As Crude Surges
“While our results clearly benefited from a favorable market, the counter-cyclical investments we made before and during the pandemic provided the energy and products people needed," said CEO Darren Woods.